Braze Q2 Earnings: Questions Answered, New Catalysts Emerge — and Why Shares Fell

Braze posted a sharp Q2 beat, with revenue of $227.2 million and adjusted EPS of $0.19, yet the shares dropped 19.15% to $24.51 after investors zeroed in on the Q3 profit outlook. The debate centers less on demand than on whether AI spending and a broader sales push will postpone operating leverage.

A Genuine Beat

As of 12:21 p.m. EDT on September 9, Braze Inc. (BRZE) shares traded at $24.51, down 19.15% for the session. The company reported Q2 revenue of $227.2 million, adjusted EPS of $0.19, and carries a market capitalization of $3.41 billion.

Second-quarter revenue grew 26.2% year-over-year to $227.2 million, surpassing the $220.23 million consensus. Adjusted EPS of $0.19 came in 26.67% above the $0.15 estimate, according to the earnings release dated September 8, 2026.

The quarter also delivered a non-GAAP operating margin of 9.7% and free cash flow of $22 million. The number of large customers rose to 361, a 28% year-over-year increase, while dollar-based net retention stood at 110%.

A complete Q2 earnings-call summary and transcript were published on September 8, 2026.

Addressing Investor Questions

1. Is enterprise demand still holding up?

Yes. Clients that spend more than $500,000 per year account for 65% of annual recurring revenue, reinforcing the enterprise up-sell thesis even as overall customer growth decelerated to 15% year over year.

2. Has AI begun to generate revenue, or is it still a demo?

AI is now contributing to the top line. BrazeAI Decisioning Studio brought in $6.6 million, a 136% year-over-year jump, with one-third of large customers using the product. The Agent Console has also been adopted by more than 650 customers.

3. Can AI products expand beyond a consultant-led model?

Management cited Decisioning Studio Go, an upcoming self-service offering, as a potential way to widen adoption and ease implementation burdens.

4. Are underlying margins on a structural improvement path?

The trajectory is favorable but inconsistent. Gross margin hit 68.6%, and operating margin climbed sharply. Still, management guided Q3 operating margin to roughly 7%, citing costs for the Forge conference and investments in new sales capacity.

5. Does the growth outlook remain intact?

Management lifted fiscal 2027 revenue guidance to $910 million to $913 million, implying around 23% growth. For Q3, revenue is guided at $229 million to $230 million, but adjusted EPS guidance came in at $0.13 to $0.14, short of analyst expectations.

Catalysts to Watch

Execution in Q3 — near-term catalyst.

The immediate test is whether Braze can hit the $229 million-to-$230 million revenue target without additional margin erosion. Consensus forecasts $227.8 million in revenue and $0.16 in adjusted EPS for the quarter.

Monetizing AI — strategic catalyst.

Investors should track Decisioning Studio revenue, paid adoption rates, and usage of Operator. The AI push needs to move beyond product engagement and translate into larger contracts and stronger net revenue retention.

AWS alliance — commercial catalyst.

The three-year partnership with AWS has the potential to broaden distribution, accelerate international growth, and deepen data integration. The real catalyst would be proof of joint customer wins rather than the deal announcement alone.

Enterprise conversions — fundamental driver.

Growth in large customers and net revenue retention are the most direct evidence that Braze is gaining share from incumbent marketing-technology providers.

Next earnings report — a calendar catalyst.

Braze's next earnings call is tentatively set for December 15, 2026, before the market opens. That report should reveal whether the company's Q3 investments generated adequate pipeline and bookings.

Key Risk Factors

Growth is decelerating: revenue growth eased from 30% in Q1 to 26.2% in Q2. Analysts also noted that current remaining performance obligation growth softened to 24%.

Margin expectations are a timing issue. The beat was not enough to prevent a selloff because investors are focused on future operating margin gains; today's spending raises the bar for margin expansion in fiscal 2027.

Analyst targets remain optimistic but vary widely: $32 at Mizuho, $35 at Stifel and Citizens, $36 at Oppenheimer, and $50 at Needham. The divergence highlights uncertainty about growth durability and the timing of margin improvement. Further coverage was published on September 8, 2026.

The Q2 report resolved questions about demand but left efficiency doubts unanswered. Bullish investors point to enterprise expansion, AI adoption, and an increased revenue forecast; bears emphasize slower growth and margin pressure in the near term.

The ultimate catalyst will be AI-fueled growth that does not come at the expense of operating leverage. Until such evidence emerges, the stock is likely to be valued as a growth company under scrutiny rather than one receiving full credit.

This article was produced with AI assistance and reviewed by an editor. See our Terms & Conditions for further information.